AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Caffeine , Anhydrous
15 registrations across 1 African market— 8 active
Markets with Caffeine , Anhydrous
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| PAINAGON TABLETS* | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Aug 2025 |
| SYNDOL | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Jun 2025 |
| CEPACOL COLD CAPSULES* | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| MEGAPYN TABLETS | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| BIOPLUS EFFERVESCENT TABLETS | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Feb 2024 |
| PARACAFF TABLETS* | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Dec 2023 |
| BSP COLD AND FLU CAPSULES* | 🇿🇦South Africa | BROVAR S & P (PTY) LTD | suspended | Jun 2022 |
| VACUDOL FORTE | 🇿🇦South Africa | ACINO PHARMA (PTY) LTD | active | Jan 1900 |
| FEVAPAR TABLETS | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| GOLDGESIC | 🇿🇦South Africa | Shanur Healthcare (Pty) Ltd | active | Jan 1900 |
| ADCO SALTERPYN TABLETS | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| DEGORAN C | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| ANTIPYN FORTE | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| PROPAIN FORTE CAPSULES | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| LENAPAIN | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
Caffeine , Anhydrous in Africa — Regulatory Overview
Caffeine , Anhydrous is registered across 1 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 15 registrations, 8 (53%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.